Please login to the form below

Not currently logged in


This page shows the latest targeting news and features for those working in and with pharma, biotech and healthcare.

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again. Aimovig will become the first CGRP receptor-targeting drug if it reaches market. ... treatments. The drug - which is vying to become the first calcitonin gene-related peptide (CGRP) receptor-targeting

Latest news

More from news
Approximately 1 fully matching, plus 657 partially matching documents found.

Latest Intelligence

  • Health on instalment Health on instalment

    Another EU drug, Strimvelis, targeting immune deficiency, retails for $665, 000.

  • The valuable brand The valuable brand

    And yet this evolutionary relic of segmentation and targeting persists long after it has become problematic, much like my love of sugar and fat. ... Like segmentation and targeting, it is an evolutionary hangover from a market environment that no longer

  • Deal Watch January 2018

    Collaboration, option. 879. Arvinas/Pfizer. Drug candidates using PROTAC (PROteolysis TArgeting Chimeras) Platform to create small molecules aimed at degrading disease-causing cellular proteins.

  • Digital

    Healthcare terms - Digital.

  • Marketing

    Healthcare terms - Marketing.

More from intelligence
Approximately 1 fully matching, plus 103 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 60 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...